wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36622125-F9C29BB3-7505-4E97-9BDF-14BE4C6DB34F
Q36622125-F9C29BB3-7505-4E97-9BDF-14BE4C6DB34F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36622125-F9C29BB3-7505-4E97-9BDF-14BE4C6DB34F
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus.
P2860
Q36622125-F9C29BB3-7505-4E97-9BDF-14BE4C6DB34F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36622125-F9C29BB3-7505-4E97-9BDF-14BE4C6DB34F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
26660a90c8ed206beb8d97ebd17e4df699cd4bfa
P2860
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial